Literature DB >> 22801302

[Chinese guideline for percutaneous coronary intervention(pocket guideline)].

.   

Abstract

Mesh：

Year:  2012        PMID： 22801302

Source DB:  PubMed          Journal:  Zhonghua Xin Xue Guan Bing Za Zhi        ISSN： 0253-3758


× No keyword cloud information.
  10 in total

1.  [Correlation between cytochrome 3A4+894C>T P450 gene polymorphism and outcomes of coronary intervention in patients with acute coronary syndrome].

Authors:  Hui Li; Miao-Nan Li; Pin-Fang Kang; Yang Li; Yang Tang; Dong-Yu Lu; Xiao-Jun Shi; Hong-Ju Wang
Journal:  Nan Fang Yi Ke Da Xue Xue Bao       Date:  2016-02-20

2.  Development of local clinical practice guidelines in the real world: an evolving scene in China.

Authors:  Joey Sw Kwong; Xin Sun
Journal:  Heart Asia       Date:  2017-06-16

3.  Effect of enoxaparin on clinical events after percutaneous coronary intervention.

Authors:  Nianzhong Tang; Shaoping Chen; Xiuying Shi; Zhong Ye; Xing Zheng
Journal:  Int J Clin Exp Med       Date:  2015-07-15

4.  Effects of recombinant human brain natriuretic peptide on the prognosis of patients with acute anterior myocardial infarction undergoing primary percutaneous coronary intervention: a prospective, multi-center, randomized clinical trial.

Authors:  Zhi-Lin Miao; Ai-Jie Hou; Hong-Yun Zang; Ru-Gang Huang; Xiao-Qun Zheng; Hai-Long Lin; Wei Wang; Ping Hou; Fei Xia; Zhan-Quan Li
Journal:  J Thorac Dis       Date:  2017-01       Impact factor: 2.895

5.  Clinical characteristics and improvement of the guideline-based management of acute myocardial infarction in China: a national retrospective analysis.

Authors:  Lechen Wang; You Zhou; Cheng Qian; Yanggan Wang
Journal:  Oncotarget       Date:  2017-07-11

6.  Clinical Significance of Cys-C and hs-CRP in Coronary Heart Disease Patients Undergoing Percutaneous Coronary Intervention.

Authors:  Zheng Tan; Li Li; Yi Ma; Xuebin Geng
Journal:  Braz J Cardiovasc Surg       Date:  2019 Jan-Feb

7.  Impacts of CYP2C19 Polymorphism and Clopidogrel Dosing on in-Stent Restenosis: A Retrospective Cohort Study in Chinese Patients.

Authors:  Min Zhang; Jiangrong Wang; Yong Zhang; Pei Zhang; Zhisheng Jia; Manyi Ren; Xiaomeng Jia; Liping Ma; Mei Gao; Yinglong Hou
Journal:  Drug Des Devel Ther       Date:  2020-02-19       Impact factor: 4.162

8.  Serum lipoprotein(a) and risk of periprocedural myocardial injury in patients undergoing percutaneous coronary intervention.

Authors:  Zhuoshan Huang; Xing Shui; Yesheng Ling; Linli Zhou; Wenqi Shi; Yanting Luo; Suhua Li; Jieming Zhu; Shujie Yu; Jinlai Liu
Journal:  Clin Cardiol       Date:  2020-12-02       Impact factor: 2.882

9.  Optimizing the duration of dual antiplatelet therapy after implantation of drug-eluting coronary stents.

Authors:  Ying Shen; Wei-Feng Shen
Journal:  Chin Med J (Engl)       Date:  2015-03-20       Impact factor: 2.628

10.  The China Patient-Centred Evaluative Assessment of Cardiac Events (China PEACE)-Prospective Study of 3-Vessel Disease: rationale and design.

Authors:  Chenfei Rao; Tasce Bongiovanni; Xi Li; Huawei Gao; Heng Zhang; Jing Li; Yan Zhao; Xin Yuan; Kun Hua; Shengshou Hu; Harlan M Krumholz; Lixin Jiang; Zhe Zheng
Journal:  BMJ Open       Date:  2016-02-15       Impact factor: 2.692
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.